|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 40012 | Randomised Phase III Intergroup Trial in Resected Stage 2 (Dukes B) Colon Cancer : 6-month Infusional 5FU-CPT11 (+/- Folinic Acid) versus Observation. Determination of Biologic Predictive and Response Factors (PETACC-4). |
| 05011 | Time finding study of chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as first or second chemotherapy line against metastatic colorectal cancer. |
| 40991 | Phase III Randomized Study of Adjuvant Immunotherapy with Monoclonal Antibody 17-1A versus no Adjuvant Therapy Following Resection for Stage II (Modified Astler Coller B2) Adenocarcinoma of the Colon |
| 40986 | CPT-11 in combination with weekly 24h infusion 5-FU plus FA relative to weekly 24h infusion 5-FU plus FA alone in patients with advanced colorectal cancer |
| 40962 | Pan-European trials in Adjuvant Colon Cancer PETACC-1 The value ofTomudex relative to standard Leucovorin-modulated bolus 5-FU. |
| 05963 | First line infusional 5-Fluorouracil, Folinic Acid and Oxaliplatin for metastatic colo-rectal cancer or loco-regional recurrency. Role of chronomodulated delivery upon survival. A multicenter randomized Phase III trial. |
| 40952 | Randomized phase III study of weekly 24 h infusion of high-dose 5-FU with or without Folinic Acid Vs bolus 5-FU plus Folinic Acid in advanced colorectal cancer (Jointly with the Arbeitsgemeinschaft fr Internistische Onkologie - AIO) |
| 40923 | Phase III clinical trial of chemotherapy with 5-Fluorouracil and L-Leucovorin following potentially curative resection of liver or lung metastases from colorectal cancer (Jointly with the National Cancer Institute of Canada (NCIC) Clinical Trials Group and the Gruppo Interdisciplinare Valutazione Interventi in Oncologia (GIVIO)) |
| 40911 | A phase III study of adjuvant regional and systemic chemotherapy in high risk resected colorectal cancers |
| 04921 | Open phase II study of the vinca alkaloid S 12363 (vinfosiltine) in advanced colorectal cancer |
| 40909 | A randomized phase II-III study of high dose 5-Fluorouracil (HD-FU) / low dose Methotrexate (LD-MTX) versus HD-FU/LD-MTX plus low dose PALA in advanced colorectal carcinoma |
| 04891 | Essais cliniques phase II d'une nouvelle nitrosourée: la Cystémustine dans les poumons, les adénocarcinomes colo-rectaux, les gliomes, les mélanomes, les reins, les sarcomes des parties molles et les tumeurs de la tête et du cou. |
| 16892C | Phase II trial of 4'-iodo-4'-deoxydoxorubicin in patients with colo-rectal cancer |
| 16871C | Phase II Chemotherapy with DuP-785 in Patients with Advanced Colorectal Cancer (Summary Last Modified 03/89) |
| 40872 | A randomized phase III study of low dose methotrexate (LD-MTX) plus high dose 5-Fluorouracil (HD-FU) versus HD-FU in advanced or metastatic colorectal carcinoma. |
| 40871 | A simple, large-scale randomized phase III trial on hepatic perfusion of 5-FU and heparin in resectable cancer of the colon and rectum |
| 16864D | Phase II Chemotherapy with Flavone Acetic Acid in Patients with Colorectal Cancer Who Have Received No Prior Chemotherapy (Summary Last Modified 03/88) |
| 04861 | Etude clinique phase II 4' -0-tetrahydropyranyl adriamycine (THP-ADM-1609 RB) |
| 16854D | Phase II trial of TCNU in non-pretreated patients with advanced colorectal cancer |
| 16841A | Phase II Chemotherapy with Menogaril in Patients with Advanced Colorectal Cancer |
| 40812 | Clinical trial on adjuvant therapy of resectable colon cancer with 5-Fluorouracil administered by portal vein perfusion. |
| 40993 | International phase III open label randomised trial comparing CPT-11 in combination with high dose 5FU/Folinic acid infusional regimen (group A) to the same high dose 5FU/Folinic acid infusional regimen (group B) alone as adjuvant treatment stage III colon cancer (PETACC-3). |
| 40983 | Pre-and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV versus Surgery alone in Resectable Liver Metastases from Colorectal Origin- Phase III Study |
| 40963 | Pan-European Trial in Adjuvant Colon Cancer- PETACC-2 Randomised phase III intergroup trial of high-dose infusional 5-FU (+ or - Folinic Acid) versus Standard bolus 5-FU/Folinic Acid. |
| 16991C | Open lablel Phase II study on XR5000 administered as a 5 day infusion in advanced colorectal cancer:EORTC study 16991C |
| 16921C | Phase II trial with Taxotere in patients with colorectal adenocarcinoma |
| 16902C | Phase II trialof Elsamitrucin (BMY 28090) in patients with colo-rectal cancer |
| 16922C | Phase II trial with Topotecan in patients with colorectal adenocarcinoma |
| 40052 | Adjuvant treatment of fully resected stage III colon cancer with folfox-4 versus folfox-4 plus cetuximab (PETACC-8) |